home / stock / nbtx / nbtx short
Short Information | Nanobiotix S.A. (NASDAQ:NBTX)
Twenty Trading Day Totals | |
---|---|
Total Shorted Volume | 35,029 |
Total Actual Volume | 173,260 |
Short Trends | |
---|---|
Cover Days | 18 |
Short Days | 1 |
No Change Days | 1 |
Averages | |
---|---|
Average Short Volume | 1,751 |
Average Short Percentage | 18.42% |
Is there a NBTX Short Squeeze or Breakout about to happen?
See the NBTX Short Analysis for free Sign up or Login
Powered by Squeeze Report
Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
---|---|---|---|---|---|---|---|
06-27-2024 | $5.4 | $5.6 | $5.6787 | $5.4 | 7,670 | 1,730 | 22.56% |
06-26-2024 | $5.31 | $5.4 | $5.48 | $5.19 | 16,839 | 3,258 | 19.35% |
06-25-2024 | $4.4 | $4.88 | $5 | $4.4 | 33,756 | 10,868 | 32.2% |
06-24-2024 | $4.29 | $4.36 | $4.36 | $4.14 | 10,792 | 3,119 | 28.9% |
06-21-2024 | $4.3 | $4.16 | $4.47 | $4.16 | 19,591 | 1,293 | 6.6% |
06-20-2024 | $4.46 | $4.2066 | $4.53 | $4.2066 | 7,893 | 711 | 9.01% |
06-18-2024 | $4.52 | $4.54 | $4.709 | $4.41 | 9,539 | 1,732 | 18.16% |
06-17-2024 | $4.64 | $4.83 | $4.86 | $4.6301 | 11,549 | 1,947 | 16.86% |
06-14-2024 | $5 | $4.6 | $5 | $4.6 | 20,242 | 5,297 | 26.17% |
06-13-2024 | $5.32 | $5.35 | $5.41 | $5.32 | 2,971 | 53 | 1.78% |
06-12-2024 | $5.6 | $5.32 | $5.6 | $5.32 | 4,285 | 911 | 21.26% |
06-11-2024 | $5.62 | $5.79 | $5.79 | $5.62 | 1,834 | 313 | 17.07% |
06-10-2024 | $5.5901 | $5.6242 | $5.6242 | $5.5901 | 1,592 | 125 | 7.85% |
06-07-2024 | $5.92 | $5.7 | $6.0096 | $5.565 | 7,599 | 980 | 12.9% |
06-06-2024 | $6.48 | $6.32 | $6.48 | $6.31 | 2,245 | 39 | 1.74% |
06-05-2024 | $6.51 | $6.42 | $6.56 | $6.3553 | 4,760 | 1,826 | 38.36% |
06-04-2024 | $6.3733 | $6.6 | $6.6 | $6.3733 | 1,366 | 245 | 17.94% |
06-03-2024 | $7.29 | $6.8 | $7.29 | $6.8 | 6,925 | 17 | 0.25% |
05-31-2024 | $7.13 | $7.04 | $7.16 | $7.04 | 1,109 | 211 | 19.03% |
05-30-2024 | $6.895 | $7 | $7 | $6.895 | 703 | 354 | 50.36% |
News, Short Squeeze, Breakout and More Instantly...
Nanobiotix S.A. Company Name:
NBTX Stock Symbol:
NASDAQ Market:
PARIS and CAMBRIDGE, Mass., June 12, 2024 (GLOBE NEWSWIRE) -- NANOBIOTIX (Euronext: NANO –– NASDAQ: NBTX – the ‘‘ Company ’’), a late-clinical stage biotechnology company pioneering physics-based approaches to expand treatment possibilities...
Data show favorable safety and feasibility in 68 heavily pre-treated patients with R/M-HNSCC (Intention-to-Treat population; “ITT”) who received RT-activated NBTXR3 followed by anti-PD-1 as a second-or-later line treatment 48% ORR in evaluable anti-PD-1 naïve patients (n=25...
New data from the completed dose escalation part and ongoing expansion part of Study 1100, an ongoing US Phase 1 study evaluating NBTXR3 followed by anti-PD-1 in patients with recurrent or metastatic head and neck cancer (n=68) to be presented by Coordinating Investigator Colette Shen, MD, PhD, a...